EUVIMEDEUVIMED entdecken
Crossref

Abstract 609: Posterior Fossa Hemangioblastomatosis with Hydrocephalus and Pheochromocytoma: A Neurovascular Presentation of Von Hippel-Lindau Disease

S. VYAS, Z. Singh, Y. Jeelani, B. Jankowitz

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von S. VYAS und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Von Hippel-Lindau (VHL) disease is a rare hereditary tumor syndrome characterized by CNS hemangioblastomas and visceral neoplasms, including pheochromocytomas. Multifocal infratentorial hemangioblastomas presenting with symptomatic hydrocephalus and concomitant biochemically active adrenal lesions create unique neurocritical care and perioperative management challenges. We present a patient whose diagnosis emerged through coordinated neurovascular, neurosurgical, endocrine, oncologic evaluation and molecularly confirmed.

Methods

A retrospective review of clinical presentation, neuroimaging, neurocritical care management, laboratory evaluation, genetic testing, and multidisciplinary decision-making was performed.

Results

25-year-old man presented with two months of progressive occipital headaches, morning emesis, photophobia, neck pain, and worsening left upper extremity paresthesias. Neurologic examination demonstrated subtle left upper extremity dysmetria and persistent sensory symptoms. CT and CTA revealed a 4.5-cm cystic right cerebellar lesion with enhancing mural nodule, numerous intensely enhancing posterior fossa lesions with feeding vessels, cervicomedullary junction mass, obstructive hydrocephalus, transependymal edema, and cerebellar tonsillar ectopia. MRI brain demonstrated approximately 50 posterior fossa enhancing lesions, multiple cystic hemangioblastoma-like lesions, partial fourth ventricular effacement, hydrocephalus, and a cervicomedullary lesion associated with cervical cord edema/syringohydromyelia. MRI thoracolumbar imaging identified an additional enhancing intramedullary conus medullaris nodule at L1. CT chest/abdomen/pelvis demonstrated bilateral adrenal masses measuring up to 5.4 cm. Given progressive hydrocephalus, the patient underwent image-guided left parieto-occipital VPS placement with laparoscopic distal catheter placement. Opening cerebrospinal fluid pressure exceeded 25 cm H₂O. Postoperative imaging demonstrated ventricular decompression and symptomatic improvement. Subsequent biochemical evaluation revealed markedly elevated plasma normetanephrine (1688 pg/mL), total free metanephrines (1729 pg/mL), 24-hour urinary normetanephrine (2694 µg/24 h), and total urinary metanephrines (2815 µg/24 h), highly concerning for pheochromocytoma. Concurrent erythrocytosis was present (peak hemoglobin 18.7 g/dL). Germline sequencing and deletion/duplication analysis identified a heterozygous pathogenic VHL variant (c.239G>T; p.Ser80Ile), confirming the diagnosis of VHL syndrome. Molecular confirmation established hereditary etiology, prompted lifelong multisystem surveillance, and initiated cascade genetic counseling and testing recommendations for first-degree relatives. Planned posterior fossa resection was deferred because of perioperative catecholamine-related anesthetic risk pending endocrine optimization and alpha-adrenergic blockade.

Conclusion

Case highlights the importance of considering hereditary tumor syndromes in young adults presenting with multifocal CNS hemangioblastomas and hydrocephalus. Molecular confirmation of the pathogenic VHL variant fundamentally influenced management by confirming diagnosis, guiding multidisciplinary decision-making, and emphasizing treatment of functional pheochromocytomas before posterior fossa surgery to avoid potentially catastrophic catecholamine-mediated complications. Integration of advanced neuroimaging, endocrine evaluation, molecular genetics, and staged neurosurgical planning is essential for optimizing outcomes in patients with VHL syndrome.

Zitieren

APA

VYAS, S., Singh, Z., Jeelani, Y., & Jankowitz, B. (2026). Abstract 609: Posterior Fossa Hemangioblastomatosis with Hydrocephalus and Pheochromocytoma: A Neurovascular Presentation of Von Hippel-Lindau Disease. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_609

Vancouver

VYAS S, Singh Z, Jeelani Y, Jankowitz B. Abstract 609: Posterior Fossa Hemangioblastomatosis with Hydrocephalus and Pheochromocytoma: A Neurovascular Presentation of Von Hippel-Lindau Disease. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_609

BibTeX
@article{VYAS2026,
  author = {VYAS, S. and Singh, Z. and Jeelani, Y. and Jankowitz, B.},
  title = {Abstract 609: Posterior Fossa Hemangioblastomatosis with Hydrocephalus and Pheochromocytoma: A Neurovascular Presentation of Von Hippel-Lindau Disease},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_609}
}
Kostenlos starten →